Submission of Audited Financial Results along with Audit Report thereon for the Quarter and year ended on 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hemo Organic Ltd reported a net loss of Rs. 77.81 lakhs for FY 2025-26, a significant decline from a profit of Rs. 16.39 lakhs in the previous year. Revenue from operations declined slightly to Rs. 241.43 lakhs from Rs. 248.42 lakhs. The auditor issued a Qualified Opinion due to lack of balance confirmations for trade receivables, trade payables, and loans & advances. The company also reversed Deferred Tax Assets of Rs. 27.93 lakhs, citing continued losses and uncertainty about future taxable profits. The company flagged that accumulated losses have exceeded paid-up capital and reserves, and current liabilities exceeded current assets as of March 31, 2026. Operating cash outflow worsened to Rs. 145.81 lakhs from Rs. 36.17 lakhs previously.
The company is facing serious financial distress with accumulated losses, negative cash flows, and a qualified audit opinion. Shareholders should be cautious as the going concern status is in doubt and the stock may face significant pressure.